MIManouchehr Iranparvar-Alamdari

Manouchehr Iranparvar-Alamdari

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Manouchehr Iranparvar-Alamdari has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effect of a Medication Adherence Education Intervention on Clinical Outcomes in Adults with Type 2 Diabetes Mellitus: A Randomized Controlled Trial Study

    by Ali Tarighat Esfanjani, Maryam Zare, Afrouz Mardi, Arezoo Haghighian-Roudsari, Maryam Rafraf, Manouchehr Iranparvar-Alamdari, Daniel Hackett, Abdolreza Shaghaghi, Mohammad Asghari Jafarabadi

    : Background: Low adherence to Oral Antidiabetic Drugs (OADs) in adults with Type 2Diabetes Mellitus (T2DM) leads to complications, death, and increased healthcare costs. Objective: This study aimed to evaluate the effectiveness of medication adherence education interventionsfor the clinical outcomes of adults with T2DM. Materials and Methods: Seventy adults with T2DM from an outpatient clinic in the City of Ardabil,Iran, participated in this study. The participants were randomized into an intervention group(n=35) or a non-interventional group (n=35). The intervention group underwent four educationalsessions focused on adherence to OADs. Content within classes was influenced by a participant'sStage of Change (SOC) result, which was related to behavior change modeling. Participants in thenon-interventional group were placed on a waiting list to receive educational content after the follow-up. Assessments were conducted at baseline, four weeks, and six months. Results: Significant improvements in Fasting Plasma Glucose (FPG) (P = 0.018) and 2-hour PlasmaGlucose (2-hPG) (P < 0.001) levels were found in the intervention group compared to the noninterventionalgroup post-intervention. Additionally, HbA1C was significantly lower at follow-upin the intervention group than in the non-intervention group (P < 0.001). The Homeostasis Modelof Insulin Resistance Assessment (HOMA-IR) revealed a significant increase in target cell sensitivityto insulin in the intervention group compared to that in the non-interventional during the follow-up period (P = 0.009). The SOC for adherence to OADs was significantly improved in the interventiongroup compared to that in the non-intervention group at the follow-up timepoint (P<0.001). Conclusion: Medication adherence education interventions may improve the clinical outcomes ofadults with T2DM.